Studies have shown that IL10-producing Bregs can suppress skin fibrosis in the Scl-cGVHD (sclerodermatous chronic graft-versus-host disease) model, an animal model of human systemic sclerosis [104]. This evidence concerns the gene IL10 and systemic sclerosis.